Highlights of ASH in Asia-Pacific 2026 (Updated with Program)

Highlights of ASH in Asia-Pacific 2026 (Updated with Program)

Highlights of ASH Day 1  (Friday, April 10, 2026)

Time Session
8:00 – 8:45 Registration and Exhibits Open
8:45 – 9:00 Welcome & Introductions
9:00 – 9:30
Changing Paradigms of Treatment Approaches for Acute Myeloid Leukemia
Katherine Tarlok, MD — University of Washington, Seattle
 
9:30 – 10:00
Integrating Approved Immunotherapies into Treatment Approaches for Adult B-Precursor Acute Lymphoblastic Leukemia
Adele K. Fielding, MBBS, PhD — Hull York Medical School, England
10:00 – 10:30 Panel Discussion
10:30 – 11:00 Coffee Break (Exhibit Hall)
11:00 – 11:45
From Bench to Bedside: Innovations in Hemoglobinopathy Treatment
Payal Desai, MD — Wake Forest University, USA
Prantar Chakrabarti, MBBS, MD, DNB, DM — Zoho for Healthcare, India
11:45 – 12:15
Artificial Intelligence and Informatics in Hematology
Barbara Lam, MD — Fred Hutchinson Cancer Center, Seattle
12:15 – 12:45 Panel Discussion
12:45 – 2:00 Lunch in Exhibit Hall (All Attendees)
Lunch with the Experts (Ticketed)
2:00 – 3:15
Tumor Board: Evolving Myeloma Treatment Paradigm
Gin Gin Gan, MD — Universiti Malaya, Kuala Lumpur
Shaji Kumar, MD — Mayo Clinic, Rochester
Hang Quach, MBBS, MD — St Vincent's Hospital, Melbourne
3:15 – 3:45 Coffee Break (Exhibit Hall)
3:45 – 4:15
Clinical Features and Management of Histiocytic Neoplasms in the Era of Targeted Therapies
Gaurav Goyal, MD — University of Alabama, Birmingham
4:15 – 4:45
Novel Insights and Emerging Therapies in Immune-Mediated Cytopenias
Michael A. Cole, MD, DPhil — Johns Hopkins Medicine, Baltimore
4:45 – 5:15 Panel Discussion
5:15 – 5:20 Highlights of ASH Day 1 Closing Remarks

Highlights of ASH Day 2  (Saturday, April 11, 2026)

Time Session
8:00 – 8:45 Registration and Exhibits Open
8:45 – 9:00 Welcome & Introductions
9:00 – 9:30
New Frontiers in Bleeding Disorders
Ross Baker, MBBS — Perth Blood Institute, Perth, Australia
9:30 – 10:00
Hematology Through a Gender Lens: Unique and Underrecognized Challenges
Sarah O'Brien, MD, MSc — Nationwide Children's, Columbus, Ohio
10:00 – 10:30 Panel Discussion
10:30 – 11:00 Coffee Break (Exhibit Hall)
11:00 – 12:15
Turning the Tide: Key Cases and Conundrums in Thrombosis Medicine
Lai Heng Lee, MBBS, MD — Singapore General Hospital, Singapore
Ponlapat Rojnuckarin, MD, PhD — Bumrungrad International Hospital, Bangkok
Jeffrey Weitz, MD — McMaster University, Ontario, Canada
12:15 – 1:30 Lunch in the Exhibit Hall (All Attendees)
Lunch with the Experts (Ticketed)
1:30 – 2:00
Updates in Management of Indolent Lymphoma and Chronic Lymphocytic Leukemia
Jia Ruan, MD, PhD — Weill Cornell Medicine, New York
2:00 – 2:45
Novel Treatment Strategies in Aggressive Lymphoma
Steven Park, MD — Wake Forest University, Winston-Salem
Eric Tse, MBBS, PhD — Hong Kong University, Hong Kong
2:45 – 3:15 Panel Discussion
3:15 – 3:45 Coffee Break (Exhibit Hall)
3:45 – 4:30
New Horizons in Transplantation and Cellular Therapies in Asia and Beyond
Robert Negrin, MD — Stanford University, California
William Hwang, MBBS — National Cancer Centre & Singapore General Hospital
4:30 – 5:00
Practice Changing Advances in Myelodysplastic Syndromes and Myeloproliferative Neoplasms
Harry Gill Singh, MBBS — HKU Med, Hong Kong
5:00 – 5:30 Panel Discussion
5:30 Highlights of ASH in Asia-Pacific Closing Remarks

MSH Annual General Meeting 2026

The Malaysian Society of Haematology will convene its Annual General Meeting (AGM) on Thursday, 9th April 2026, at the Shangri-La Hotel, Kuala Lumpur, from 6:00 pm to 8:00 pm.

The meeting will also include the biennial election of the Society’s office bearers.

MSH ASM 2026

MSH ASM 2026

 

We are pleased to announce that delegate registration for the 23rd Malaysian Society of Haematology Annual Scientific Meeting (MSH ASM 2026)

IS NOW OPEN.

Join us on 24-25 July 2026 at Sheraton Johor Bharu for a CPD-accredited scientific programme focused on advancing haematology practice,

with an emphasis on equity, innovation, and real-world impact.

This will be followed by a Post-Congress Workshop on 26 july 2026.

Abstract submission opens on 1st April 2026, and accepted abstract authors will be eligible for a refund or registration fees (terms and condition apply).

Early bird pricing has been extended to 1st May 2026, offereing delegates the opportunity to secure their participation at a preferential rate with advance registration.

For registration details and contact information, please visit CONFERENCE SITE.

 

#MSH #Haematology #MSHASM2026 #HematologyConference #MedicalEducation #JohorBahru #MSH2026

Delegate's Prospectus